Sunergia Medical

Sunergia Medical is an innovative medical device company based in Israel, specializing in the field of structural heart interventions. The company is developing a novel transcatheter mitral valve replacement (TMVR) system designed to treat patients with severe mitral regurgitation. A key differentiator of Sunergia's technology is its focus on minimizing the risk of Left Ventricular Outflow Tract (LVOT) obstruction, which is a significant barrier to successful TMVR in many patients. The device features a unique anchoring mechanism intended to ensure stable positioning and optimal hemodynamic performance. Currently in the pre-clinical phase, Sunergia Medical is working toward clinical trials to demonstrate the safety and efficacy of its transcatheter solution.